Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of underserved patients. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span the cardiovascular, neurology, endocrinology, gastro-intestinal, institutional, and orphan markets, and have benefited millions of patients. For more information, visit www.azurity.com.

Azurity Pharmaceuticals is proud to be an inclusive workplace and an Equal Opportunity Employer. Azurity's success is attributable to our incredibly talented, dedicated team that focuses on benefiting the lives of patients by bringing the best science and commitment to quality into everything that we do. We seek highly motivated individuals with the dedication, integrity, and creative spirit needed to thrive in our organization.

About the Role

Azurity Pharmaceuticals is a privately held specialty pharmaceutical company focused on innovative products that meet the needs of underserved patients. Within the Surgical Business Unit — our hospital-focused, targeted-delivery specialty business — we are preparing to launch D-PLEX100, a locally administered, extended-release surgical anti-infective for the prevention of surgical site infection.

We are seeking a Head of Marketing (Senior Director) to own US brand strategy and launch for D-PLEX100. Reporting to the VP, NA Commercial Brand Executive for Oncology, this individual is the US marketing lead for the asset — responsible for brand strategy, positioning, launch planning and readiness, and in-line execution across the hospital and surgical setting. D-PLEX100 is an inpatient, DRG-reimbursed product whose adoption is governed at the account level by institutional Pharmacy & Therapeutics (P&T) committees; success depends on winning formulary approval and building protocol-level demand, not on individual prescribing alone. The role leads a small brand team, directs external agencies, and partners closely with Market Access/HEOR, Medical Affairs, Sales, Regulatory, and Program Management to bring a differentiated, reimbursement-dependent hospital product to market.

This role has two direct reports — a Director, Brand Marketing (primarily, but not limited to, in-line HCP marketing execution and campaign/agency management) and a Senior Manager, Brand Marketing – Institutional (primarily, but not limited to, institutional and account-facing materials, congress and KOL logistics)

The ideal candidate brings a minimum of 12 years in pharmaceutical or biotech, including at least 6 years of US marketing experience working with DRG-reimbursed hospital, surgical, and/or anti-infective products, and prior people-management experience. This is a US-focused role in a fast-paced, launch-stage environment that rewards a hands-on, collaborative leader.

Key Responsibilities

Brand Strategy & Execution

• Own US brand strategy for D-PLEX100 — positioning, value proposition, messaging, and the integrated marketing plan — aligned to corporate and commercial objectives and to the DRG/NTAP reimbursement pathway.

• Develop and execute the launch and in-line marketing plan for the hospital and surgical setting, ensuring timely development, medical/legal/regulatory review, production, and deployment of campaigns and materials.

• Monitor brand performance, KPIs, and market dynamics — including P&T and formulary access, protocol adoption, and account-level uptake — to optimize strategy and inform tactical pivots.

• Commission and interpret primary and secondary market research to build surgeon, pharmacy, and institutional insight and to inform brand strategy.

Institutional Access & P&T Strategy

• Build the account-level adoption strategy for a P&T-governed product: the formulary value story, P&T submission tools, and pull-through plan that move D-PLEX100 from approval to protocol inclusion at target institutions.
• Partner with Market Access/HEOR and Contracting to align the brand on pricing, coding, DRG economics, and inpatient add-on payment (NTAP) dynamics, so the value proposition speaks to the hospital budget-holder, not only the clinician.
• Equip the field and account teams to engage pharmacy directors, infection-prevention and antimicrobial-stewardship leads, surgeons, and value-analysis committees with a consistent, compliant institutional value story.

Launch Planning & Readiness

• Lead cross-functional US launch readiness for D-PLEX100 and subsequent indications, partnering with Program Management on the integrated launch plan and readiness gates.
• Build US launch timelines, field execution strategy, and training and promotional materials, sequenced to regulatory approval and the reimbursement and coding milestones that gate the commercial model.
• Ensure demand generation and access readiness (formulary tools, P&T submissions, coding support) are sequenced together so uptake is not gated by avoidable access gaps.
• Partner with Medical Affairs, Regulatory, and external agencies to deliver high-quality, compliant promotional and educational content.

Portfolio & Lifecycle Management

• Manage D-PLEX100 across its lifecycle stages (pre-launch, launch, growth), prioritizing and allocating budget across tactics to maximize impact and return.
• Support indication-expansion planning by developing positioning and demand-generation strategy for new surgical settings as they advance.
• Continually assess the competitive and standard-of-care landscape — including infection-prevention bundles and protocol inertia — and revise strategy accordingly.
• Work with sales training, commercial partners, and medical and legal teams to develop and implement commercial training for the franchise.

Team Leadership

• Hire, develop, and lead two direct reports (Director, Brand Marketing; Senior Manager, Brand Marketing – Institutional), setting objectives, allocating work across the brand plan, and building marketing capability on the franchise.
• Provide day-to-day direction and coaching, manage performance, and ensure the team delivers compliant, on-time, on-strategy execution.

Stakeholder & Team Collaboration

• Serve as the key liaison between marketing and the hospital field force, driving alignment on strategy and messaging.
• Engage surgeon and pharmacy KOLs and institutional decision-makers to gather insight and inform brand planning and positioning.
• Collaborate with external partners, agencies, and vendors to develop omnichannel campaigns tailored to hospital and surgical audiences.
• Coordinate with the licensor/alliance interface, via Program Management, on brand-relevant deliverables and evidence needs.

Measures of Success

• Launch readiness: brand launch gates are met to defined criteria and on schedule, with promotional and training materials approved and field-ready at launch.
• Formulary access: target-account P&T submissions and formulary wins track to plan, converting approval into protocol-level adoption.
• Brand performance: awareness, protocol adoption, formulary access, and account-level uptake track to or ahead of established brand goals.
• Execution quality: campaigns and materials clear medical/legal/regulatory review on time and sustain compliant, consistent brand messaging in-market.
• Team: both direct reports are hired, ramped, and delivering to objectives, with clear development plans in place.

Required Skills and Experience

• Bachelor's degree in Marketing, Life Sciences, Business, or a related field required; MBA or advanced degree preferred.
• 12+ years in the pharmaceutical or biotech industry, including 6+ years of US in-line marketing and launch experience.
• Experience marketing DRG-reimbursed inpatient or hospital-administered products where institutional P&T / formulary access governs adoption.
• Prior people-management experience, with a track record of hiring, developing, and leading marketing talent.
• Proven ownership of brand strategy and launch for one or more products, including positioning, integrated planning, and cross-functional execution.
• Proven ability to manage multiple brands or indications simultaneously in a fast-paced, evolving organization, with a hands-on, collaborative approach.
• Strong cross-functional leadership and communication skills, including the ability to align a field force and external agencies around a single brand strategy.
• Experience partnering with Market Access/HEOR, Medical Affairs, Sales, and Regulatory on compliant promotional and educational content.
• Willingness to travel ~20–30% (including conferences, sales meetings, and field rides).

Preferred Qualifications

• Hospital anti-infective, surgical, or other inpatient buy-and-bill product experience strongly preferred.
• Direct experience building P&T / formulary access strategy and pull-through for an institutionally governed product.
• Familiarity with inpatient reimbursement and coding dynamics (MS-DRG, new technology add-on payment / NTAP, HCPCS/J-code strategy) and antimicrobial-stewardship / infection-prevention stakeholders.
• Launch experience with an in-licensed or newly acquired asset.
• Drug-device combination or novel-delivery product marketing experience.

#LI-Hybrid
#LI-Full-time

The California Consumer Privacy Act regulates privacy rights and consumer protection for residents of California, United States. For details, click here.

The General Data Protection Regulation (GDPR) sets guidelines for the collection and processing of personal information from individuals who live in the European Union (EU).